001     280788
005     20250907001911.0
024 7 _ |a 10.1038/s41586-025-09190-w
|2 doi
024 7 _ |a pmid:40533564
|2 pmid
024 7 _ |a pmc:PMC12367551
|2 pmc
024 7 _ |a 0028-0836
|2 ISSN
024 7 _ |a 1476-4687
|2 ISSN
024 7 _ |a altmetric:178165286
|2 altmetric
037 _ _ |a DZNE-2025-00972
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Huang, Hao
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Kupffer cell programming by maternal obesity triggers fatty liver disease.
260 _ _ |a London [u.a.]
|c 2025
|b Nature Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1756206979_31521
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Kupffer cells (KCs) are tissue-resident macrophages that colonize the liver early during embryogenesis1. Upon liver colonization, KCs rapidly acquire a tissue-specific transcriptional signature, mature alongside the developing liver and adapt to its functions1-3. Throughout development and adulthood, KCs perform distinct core functions that are essential for liver and organismal homeostasis, including supporting fetal erythropoiesis, postnatal erythrocyte recycling and liver metabolism4. However, whether perturbations of macrophage core functions during development contribute to or cause disease at postnatal stages is poorly understood. Here, we utilize a mouse model of maternal obesity to perturb KC functions during gestation. We show that offspring exposed to maternal obesity develop fatty liver disease, driven by aberrant developmental programming of KCs that persists into adulthood. Programmed KCs promote lipid uptake by hepatocytes through apolipoprotein secretion. KC depletion in neonate mice born to obese mothers, followed by replenishment with naive monocytes, rescues fatty liver disease. Furthermore, genetic ablation of the gene encoding hypoxia-inducible factor-α (HIF1α) in macrophages during gestation prevents the metabolic programming of KCs from oxidative phosphorylation to glycolysis, thereby averting the development of fatty liver disease. These results establish developmental perturbation of KC functions as a causal factor in fatty liver disease in adulthood and position fetal-derived macrophages as critical intergenerational messengers within the concept of developmental origins of health and diseases5.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 1
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 2
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Hypoxia-Inducible Factor 1, alpha Subunit
|2 NLM Chemicals
650 _ 7 |a Hif1a protein, mouse
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Kupffer Cells: metabolism
|2 MeSH
650 _ 2 |a Kupffer Cells: pathology
|2 MeSH
650 _ 2 |a Kupffer Cells: cytology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Pregnancy
|2 MeSH
650 _ 2 |a Hypoxia-Inducible Factor 1, alpha Subunit: genetics
|2 MeSH
650 _ 2 |a Hypoxia-Inducible Factor 1, alpha Subunit: metabolism
|2 MeSH
650 _ 2 |a Hypoxia-Inducible Factor 1, alpha Subunit: deficiency
|2 MeSH
650 _ 2 |a Pregnancy in Obesity: pathology
|2 MeSH
650 _ 2 |a Pregnancy in Obesity: metabolism
|2 MeSH
650 _ 2 |a Fatty Liver: pathology
|2 MeSH
650 _ 2 |a Fatty Liver: etiology
|2 MeSH
650 _ 2 |a Fatty Liver: metabolism
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Liver: metabolism
|2 MeSH
650 _ 2 |a Liver: pathology
|2 MeSH
650 _ 2 |a Liver: embryology
|2 MeSH
650 _ 2 |a Liver: cytology
|2 MeSH
650 _ 2 |a Glycolysis
|2 MeSH
650 _ 2 |a Hepatocytes: metabolism
|2 MeSH
650 _ 2 |a Animals, Newborn
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Oxidative Phosphorylation
|2 MeSH
650 _ 2 |a Prenatal Exposure Delayed Effects: pathology
|2 MeSH
650 _ 2 |a Mice, Inbred C57BL
|2 MeSH
650 _ 2 |a Macrophages: metabolism
|2 MeSH
650 _ 2 |a Obesity: complications
|2 MeSH
693 _ _ |0 EXP:(DE-2719)PRECISE-20190321
|5 EXP:(DE-2719)PRECISE-20190321
|e Platform for Single Cell Genomics and Epigenomics at DZNE University of Bonn
|x 0
700 1 _ |a Balzer, Nora
|0 P:(DE-2719)9002224
|b 1
|u dzne
700 1 _ |a Seep, Lea
|0 0000-0002-0399-1896
|b 2
700 1 _ |a Splichalova, Iva
|b 3
700 1 _ |a Blank-Stein, Nelli
|b 4
700 1 _ |a Viola, Maria Francesca
|0 0000-0003-0660-9506
|b 5
700 1 _ |a Franco Taveras, Eliana
|0 0009-0009-2227-6765
|b 6
700 1 _ |a Acil, Kerim
|0 0009-0002-7838-9928
|b 7
700 1 _ |a Fink, Diana
|0 0009-0008-1572-4390
|b 8
700 1 _ |a Petrovic, Franzisca
|b 9
700 1 _ |a Makdissi, Nikola
|0 P:(DE-2719)9002664
|b 10
|u dzne
700 1 _ |a Bayar, Seyhmus
|0 0000-0001-7077-8748
|b 11
700 1 _ |a Mauel, Katharina
|0 0009-0007-4879-032X
|b 12
700 1 _ |a Radwaniak, Carolin
|0 0009-0007-7908-1067
|b 13
700 1 _ |a Zurkovic, Jelena
|0 0000-0002-5932-4849
|b 14
700 1 _ |a Kayvanjoo, Amir H
|0 0000-0003-1315-8336
|b 15
700 1 _ |a Wunderling, Klaus
|0 0000-0003-1237-7510
|b 16
700 1 _ |a Jessen, Malin
|0 0009-0007-5929-0064
|b 17
700 1 _ |a Yaghmour, Mohamed H
|b 18
700 1 _ |a Kenner, Lukas
|0 0000-0003-2184-1338
|b 19
700 1 _ |a Ulas, Thomas
|0 P:(DE-2719)9000845
|b 20
700 1 _ |a Grein, Stephan
|0 0000-0001-9524-6633
|b 21
700 1 _ |a Schultze, Joachim L
|0 P:(DE-2719)2811660
|b 22
|u dzne
700 1 _ |a Scott, Charlotte L
|0 0000-0003-4914-6580
|b 23
700 1 _ |a Guilliams, Martin
|b 24
700 1 _ |a Liu, Zhaoyuan
|0 0000-0002-3117-0833
|b 25
700 1 _ |a Ginhoux, Florent
|0 0000-0002-2857-7755
|b 26
700 1 _ |a Beyer, Marc D
|0 P:(DE-2719)2812219
|b 27
700 1 _ |a Thiele, Christoph
|0 0000-0001-5161-2558
|b 28
700 1 _ |a Meissner, Felix
|0 0000-0003-1000-7989
|b 29
700 1 _ |a Hasenauer, Jan
|b 30
700 1 _ |a Wachten, Dagmar
|0 P:(DE-2719)9002895
|b 31
700 1 _ |a Mass, Elvira
|0 0000-0003-2318-2356
|b 32
773 _ _ |a 10.1038/s41586-025-09190-w
|g Vol. 644, no. 8077, p. 790 - 798
|0 PERI:(DE-600)1413423-8
|n 8077
|p 790 - 798
|t Nature
|v 644
|y 2025
|x 0028-0836
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/280788/files/DZNE-2025-00972.pdf
856 4 _ |u https://pub.dzne.de/record/280788/files/DZNE-2025-00972%20SUP%2BSRC.zip
856 4 _ |u https://pub.dzne.de/record/280788/files/DZNE-2025-00972.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:280788
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 1
|6 P:(DE-2719)9002224
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 10
|6 P:(DE-2719)9002664
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)9000845
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 22
|6 P:(DE-2719)2811660
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 27
|6 P:(DE-2719)2812219
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 1
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 2
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2025-01-06
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-06
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a IF >= 60
|0 StatID:(DE-HGF)9960
|2 StatID
|b NATURE : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1210
|2 StatID
|b Index Chemicus
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1200
|2 StatID
|b Chemical Reactions
|d 2025-01-06
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NATURE : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
920 1 _ |0 I:(DE-2719)1013038
|k AG Schultze
|l Clinical Single Cell Omics (CSCO) / Systems Medicine
|x 0
920 1 _ |0 I:(DE-2719)1013035
|k AG Beyer
|l Immunogenomics and Neurodegeneration
|x 1
920 1 _ |0 I:(DE-2719)1013031
|k PRECISE
|l Platform for Single Cell Genomics and Epigenomics
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013038
980 _ _ |a I:(DE-2719)1013035
980 _ _ |a I:(DE-2719)1013031
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21